The appeals ruling involved a class-action suit filed by relatives of alleged asbestos victims who accused BASF and Cahill of a systematic cover-up involving the destruction of key documents involving Engelhard asbestos litigation. Although the case in itself is not injury related, evidence of a cover-up could revive many previously litigated cases and cases in which plaintiffs settled for less than they would have had they attained access to factual information.
Health & Medicine
According to the FDA, Persons infected with the salmonella organism “often experience fever, diarrhea (which may be bloody), nausea, vomiting and abdominal pain” that in rare circumstances, “can result in the organism getting into the bloodstream and producing more severe illnesses such as arterial infections (i.e., infected aneurysms), endocarditis and arthritis.”
The U.S. Court of Appeals for the Federal Circuit granted a major victory for Novartis AG, the world’s pharmaceutical market leader. The court’s three-judge panel ruled 2-1 on Wednesday, declining a petition to renew a six-month injunction filed by competitor Amgen involving the marketing of a biosimilar drug comparable to Amgen’s breakthrough cancer treatment Neupogen
Five companies that sell pure powdered caffeine received warnings from the FDA to immediately correct violations or be subject to product seizure. The danger, according to the FDA, is that the amounts of the product being sold in individual packages is too much and that it is too difficult to properly measure with normal kitchen utensils.
William L. filed suit against 3M and Arizant Healthcare, Inc. claiming that their Bair Hugger caused him to develop an infection requiring additional surgeries and leaving him with permanent injuries. A patient warmer, the Bair Hugger blows hot air right onto the patient’s exposed skin during surgery.
The risk of pain is serious enough that the FDA added a new “Warning and Precaution” to the labels of all drugs in this class. These include sitagliptin, saxagliptin, linagliptin, and alogliptin. The FDA issues warning about type 2 diabetes drugs and joint pain, stating that the pain may be severe and disabling.
C.R. Bard settles vaginal mesh lawsuits for $200M. This agreement comes after five years of expensive legal battles. Over 3,000 women claiming that implantation of Bard’s bladder or vaginal sling caused them injuries filed the suits being settled. The products are commonly used in surgeries treating stress urinary incontinence or pelvic organ prolapse. This isn’t
Lovaza, a popular prescription Omega-3 fish oil, may cause subdural hematoma. Omega-3s, essential for human health, may also contribute to increased risk of bleeding. As many who suffer from chronic subdural hematoma are elderly and, therefore, more likely to need Lovaza, this risk increases. To date, GSK’s warning does not include subdural hematoma.
Psych ward escapee dies in traffic, court rules medical malpractice. After Ashley Lawson, patient as Shands Vista psychiatric hospital, stole an employee’s badge and keys, she escaped and fled onto Interstate 75 where she was killed when a truck hit her. Her estate sued the hospital for negligence, but the 1st District Court of Appeal ruled that it properly sounded in medical malpractice. This resulted in the case being dismissed as the estate didn’t meet the notice provisions for a medmal case. However, it was dismissed without prejudice, meaning the estate can try again.
The terms of the agreement include Valeant paying AstraZeneca $100 million up front, adding another $170 million depending on pre-launch benchmarks, as well as up to $175 million depending upon sales benchmarks. After the product’s launch, the two companies will share profits. Valeant will handle the regulatory submission processes and the associated costs. In return, Valeant will retain the commercialization rights to brodalumab in all markets except in Japan and some Asian countries, where Amgen, the originator of the drug, had made a pre-existing agreement with Japanese biotech firm Kyowa Hakko Kirin.